ES8105331A1 - Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido - Google Patents

Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido

Info

Publication number
ES8105331A1
ES8105331A1 ES492332A ES492332A ES8105331A1 ES 8105331 A1 ES8105331 A1 ES 8105331A1 ES 492332 A ES492332 A ES 492332A ES 492332 A ES492332 A ES 492332A ES 8105331 A1 ES8105331 A1 ES 8105331A1
Authority
ES
Spain
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
peptide derivatives
ergot peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES492332A
Other languages
English (en)
Other versions
ES492332A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH547679A external-priority patent/CH642082A5/de
Priority claimed from CH547779A external-priority patent/CH643560A5/de
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES8105331A1 publication Critical patent/ES8105331A1/es
Publication of ES492332A0 publication Critical patent/ES492332A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DEL ALCALOIDE 2-METIL-8(R) O (S) ERGOT-PEPTIDO. CONSISTE EN EFECTUAR ALGUNA DE LAS SIGUIENTES OPERACIONES: 1. CONDENSAR UNA SAL DE ADICION DE ACIDO DE UN AMINOCICLOL CON UN DERIVADO ACIDO DEL CORRESPONDIENTE ACIDO 2-METIL-LISERGICO. 2. REDUCIR UN ALCALOIDE DE ERGOT-PEPTIDO SUSTITUIDO EN LA POSICION 2 CON UN RADICAL DITIOMETINA O TIOMETILENO REDUCIBLE CAPAZ DE REDUCIRSE A UN GRUPO METILO; O 3. INTRODUCIR UN GRUPO METILO EN LA POSICION 2 DE UN ALCALOIDE DE ERGOT-PEPTIDO CICLICO INSUSTITUIDO EN LA POSICION 2.
ES492332A 1979-06-12 1980-06-11 Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido Granted ES492332A0 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH547679A CH642082A5 (en) 1979-06-12 1979-06-12 Ergopeptin derivatives, their preparation and use
CH547979 1979-06-12
CH547779A CH643560A5 (en) 1979-06-12 1979-06-12 Ergopeptin derivatives, their preparation and use
CH547879 1979-06-12

Publications (2)

Publication Number Publication Date
ES8105331A1 true ES8105331A1 (es) 1981-05-16
ES492332A0 ES492332A0 (es) 1981-05-16

Family

ID=27428898

Family Applications (3)

Application Number Title Priority Date Filing Date
ES492332A Granted ES492332A0 (es) 1979-06-12 1980-06-11 Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido
ES498871A Expired ES8205194A1 (es) 1979-06-12 1981-01-28 Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido
ES498872A Expired ES8205195A1 (es) 1979-06-12 1981-01-28 Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES498871A Expired ES8205194A1 (es) 1979-06-12 1981-01-28 Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido
ES498872A Expired ES8205195A1 (es) 1979-06-12 1981-01-28 Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido

Country Status (24)

Country Link
US (1) US4547500A (es)
AR (1) AR231142A1 (es)
AU (1) AU545645B2 (es)
CA (1) CA1169856A (es)
CY (1) CY1331A (es)
DE (1) DE3020895A1 (es)
DK (1) DK250580A (es)
ES (3) ES492332A0 (es)
FI (1) FI70222C (es)
FR (1) FR2458552A1 (es)
GB (2) GB2053908B (es)
HK (1) HK40286A (es)
HU (1) HU184299B (es)
IE (1) IE49610B1 (es)
IL (1) IL60287A (es)
IT (1) IT1146938B (es)
KE (1) KE3622A (es)
MA (1) MA18872A1 (es)
NL (1) NL8003318A (es)
NO (1) NO154635C (es)
NZ (1) NZ193992A (es)
PH (1) PH19334A (es)
PT (1) PT71374B (es)
SE (2) SE445645B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571927B2 (en) * 1979-06-12 1988-04-28 Sandoz Ltd. A 2-methyl ergot peptide alkaloid
CH656533A5 (de) * 1982-12-10 1986-07-15 Sandoz Ag Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
JP2014517076A (ja) * 2011-06-23 2014-07-17 マップ・ファーマシューティカルズ・インコーポレイテッド 新規のフルオロエルゴリン類似体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
CH588485A5 (en) * 1973-10-12 1977-06-15 Sandoz Ag (17)-Ergolene derivs. prepn. - from lysergic acid (6)-(N)-oxide derivs.
CH587858A5 (es) * 1973-11-28 1977-05-13 Sandoz Ag
CH610330A5 (en) * 1974-09-27 1979-04-12 Sandoz Ag Process for the preparation of novel ergopeptins
CH601321A5 (es) * 1975-01-06 1978-07-14 Sandoz Ag
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives

Also Published As

Publication number Publication date
FR2458552B1 (es) 1983-08-19
HK40286A (en) 1986-06-06
SE8500490L (sv) 1985-02-04
FI801810A7 (fi) 1980-12-13
IE801206L (en) 1980-12-12
SE445645B (sv) 1986-07-07
NZ193992A (en) 1982-12-21
IE49610B1 (en) 1985-10-30
ES498872A0 (es) 1982-06-01
AR231142A1 (es) 1984-09-28
NO801724L (no) 1980-12-15
GB2053908A (en) 1981-02-11
FR2458552A1 (fr) 1981-01-02
IL60287A0 (en) 1980-09-16
NO154635B (no) 1986-08-11
NO154635C (no) 1986-11-19
CA1169856A (en) 1984-06-26
DE3020895A1 (de) 1980-12-18
PT71374A (en) 1980-07-01
IL60287A (en) 1986-03-31
GB2053908B (en) 1983-11-30
US4547500A (en) 1985-10-15
ES498871A0 (es) 1982-06-01
FI70222C (fi) 1986-09-15
CY1331A (en) 1986-06-27
NL8003318A (nl) 1980-12-16
ES492332A0 (es) 1981-05-16
AU5923380A (en) 1980-12-18
AU545645B2 (en) 1985-07-25
IT1146938B (it) 1986-11-19
KE3622A (en) 1986-05-16
PT71374B (en) 1981-06-25
GB2121030B (en) 1984-05-23
ES8205194A1 (es) 1982-06-01
MA18872A1 (fr) 1980-12-31
ES8205195A1 (es) 1982-06-01
PH19334A (en) 1986-03-21
SE457260B (sv) 1988-12-12
HU184299B (en) 1984-07-30
GB2121030A (en) 1983-12-14
SE8500490D0 (sv) 1985-02-04
IT8048924A0 (it) 1980-06-10
SE8004306L (sv) 1980-12-13
FI70222B (fi) 1986-02-28
DK250580A (da) 1980-12-13

Similar Documents

Publication Publication Date Title
RO91197B (ro) Procedeu pentru prepararea unor derivati de piridazinamina
IE811275L (en) Vinblastines
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
ES8105331A1 (es) Procedimiento para preparar un alcaloide 2-metil-8(r) o (s) ergotpeptido
IL108085A0 (en) Serotoninergic ergoline derivatives their preparation and pharmacutical compositions containing them
EP0272596A3 (en) Theophyllinemethyldithiolan and theophyllinemethyldithianyl derivates, a method for their preparation and pharmaceutical compositions in which they are included
AU7001687A (en) Composition, process for making and use of n-(2(2-hydroxy-3- phenoxypnopyl)aminoethyl)isobutyramide
AU1726183A (en) Ursolic acid derivatives
NZ189087A (en) Amino derivatives of tetracyclo (4,3,0,0,0)nonane and pharmaceutical compositions
GB2258397B (en) Pharmaceutical compositions containing amethocaine
AU581856B2 (en) 1-(4'-alkylthiophenyl)-2-amino-1, 3-propanediol N-substituted derivatives
ES482084A1 (es) Un procedimiento para preparar un compuesto.
IL53506A (en) Spiro-3,5"-oxazolidine-2",4"-dione derivatives of 3-descarbo-methoxy-3-deshydroxy vinca alkaloids,pharmaceutical compositions containing them and vinca alkaloid 3-carbamates as intermediates therefor
MY101535A (en) Pharmaceutical compositions
IL56457A0 (en) Ergot peptide alkaloid derivatives, their preparation and pharmaceutical compositions containing them
IE832939L (en) Pharmaceutical composition.
HUT40801A (en) Process for preparing benzo-thiopyrano- and benzthieno-pyrazolov
ZA803516B (en) Ergot peptide derivatives,their preparation and pharmaceutical compositions containing them
SE8301530D0 (sv) Pharmaceutical compositions containing a dibenzocycloheptadiene anti-depressant and an ergot alkaloid